NCT03322436View on ClinicalTrials.gov

HeartLinc, a Study With AMI Patients Undergoing PCI

CompletedOBSERVATIONAL
Enrollment

240

Participants

Timeline

Start Date

March 13, 2018

Primary Completion Date

July 30, 2022

Study Completion Date

October 31, 2022

Conditions
AMI Patients
Interventions
DIAGNOSTIC_TEST

HeartLinc kit

Samples are collected and analyzed afterwards

Trial Locations (2)

31059

CHU de TOULOUSE, Toulouse

Unknown

SNUH, Seoul

Sponsors

Lead Sponsor

Firalis SA
All Listed Sponsors
lead

Firalis SA

INDUSTRY

NCT03322436 - HeartLinc, a Study With AMI Patients Undergoing PCI | Biotech Hunter | Biotech Hunter